Antibiotic resistance in pneumococci is due to the spread of strains belonging to a limited number of clones. The Spain 9V -3 clone of sequence type (ST)156 is one of the most successful clones with reduced susceptibility to penicillin [pneumococci nonsusceptible to penicillin (PNSP)]. In Sweden during 2000 -2003, a dramatic increase in the number of PNSP isolates was observed. Molecular characterization of these isolates showed that a single clone of sequence type ST156 increased from 40% to 80% of all serotype 14, thus causing the serotype expansion. Additionally, during the same time period, we examined the clonal composition of two serotypes 9V and 19F: all 9V and 20% of 19F isolates belonged to the clonal cluster of ST156, and overall Ϸ50% of all PNSP belonged to the ST156 clonal cluster. Moreover, microarray and PCR analysis showed that all ST156 isolates, irrespective of capsular type, carried the rlrA pilus islet. This islet was also found to be present in the penicillin-sensitive ST162 clone, which is believed to be the drug-susceptible ancestor of ST156. Competitive experiments between related ST156 serotype 19F strains confirmed that those containing the rlrA pilus islet were more successful in an animal model of carriage. We conclude that the pilus island is an important biological factor common to ST156 isolates and other successful PNSP clones. In Sweden, a country where the low antibiotic usage does not explain the spread of resistant strains, at least 70% of all PNSP isolates collected during year 2003 carried the pilus islet.
S
treptococcus pneumoniae, a frequent colonizer of the nasopharynx of healthy children, and a major cause of invasive disease in children and the elderly, is found with at least 90 different capsular serotypes. Antibiotic resistance in pneumococci is primarily due to horizontal gene transfer events, which may explain why resistance is primarily observed in serotypes frequently found in the nasopharynx of healthy preschool children, an ecological niche inhabited by several streptococcal species providing a source for resistance determinants. The increased occurrence of antibiotic resistance in several geographic regions is however not serotype restricted, and it is reportedly due to the spread of a limited number of antibiotic-resistant clones (1) . Clonal success, as estimated by the spread of particular clones, is not well understood, and it has been suggested to be due to the presence of yet-unknown virulence factors (2) . In fact, antibiotic-resistant pneumococcal clones have been shown to spread despite an overall decrease in antibiotic consumption (3) , suggesting that selection of these clones may also be due to factors different from those associated with antibiotic resistance.
Successful international clones carrying resistance determinants have been recognized, such as the Spain 6B -2 and the Spain 9V -3 clones (1) . The dissemination of the Spain 6B -2 clone was the reason for the increased resistance rates observed among pneumococci between 1989 and the early to mid-1990s in Iceland (4) . The Spain 9V -3 clone [sequence type (ST)156], known to be resistant to penicillin and trimethoprim-sulfametoxazole and common among pneumococci nonsusceptible to penicillin (PNSP), has been reported to spread to most countries in Europe and to be present on all continents worldwide (5) . Furthermore, isolates belonging to the ST156 clonal cluster have been found to express a variety of serotypes such as types 6B, 9A, 11A, 14, 15B/C, 19A, 19F, 23F, and 24F, suggesting a high propensity of this clonal cluster to undergo capsular switch events.
The present study was undertaken to gain insights into the mechanisms of expansion of the Spain 9V -3 ST156 clone in Sweden, a country with relatively low antibiotic consumption. This clone was found to comprise all PNSP with capsular serotype 9V and to dramatically expand as a capsular switch variant of serotype 14.
Comparative genomics revealed that PNSP isolates belonging to the Spain 9V -3 clone carry the rlrA islet encoding adhesive pili, which were recently shown to promote colonization as well as virulence as shown by studying survival and bacterial load in an intranasal infection animal model (6) . Our findings suggest that Spain 9V -3 has evolved from an already piliated penicillin-susceptible ancestor (ST162) and that expression of adhesive pili by Spain 9V -3 isolates contributes to the successful competition with other nonpiliated PNSP isolates. However, we did not observe a competitive advantage toward already piliated non-ST156 clones.
Results and Discussion
Expansion of the International Spain 9V -3 Clone Among PNSP in Sweden. To better understand which factors influence the capability of clonal expansion within a geographical region, all S. pneumoniae isolates with reduced susceptibility to penicillin (PNSP) in Sweden were characterized between 1997 to 2003. Surveillance of pneumococci has identified serogroup 9 as the predominating serogroup among PNSP in Sweden (7) . This serogroup accounted for 20-50% of all PNSP (isolated both from carriage and disease) (7), although serotypes 14 and 19F were also frequently found. During 2000-2003, 98% (647/655) of the serogroup 9 isolates were characterized as serotype 9V, and a majority of these had additional resistance to trimetoprim/sulfametoxazole. Eighty randomly selected representatives of these 647 type 9V isolates were further analyzed by pulsed field gel electrophoresis (PFGE) and were all shown to be highly genetically related (i.e., belonging to a single clone). Multilocus sequence typing (MLST) of 12 serotype 9V isolates revealed that they all belonged to the highly successful international Spain 9V -3 clone of ST156 reported to be present on all continents (Fig. 1) .
During the past years, Sweden also observed a rapid increase of capsular type 14 PNSP isolates, from 12% in 1999 to 26% in 2003 ( Fig. 2A) (Fig. 2B) . In addition to serotype 9 and 14, clonal cluster ST156 was also found to represent 20% of serotype 19F isolates (Fig. 2B) To assess genomic differences among PNSP frequently isolated from Sweden, we selected four isolates of ST156 belonging to serotypes 9V and 14 and compared these to isolates belonging to non-ST156 clones of the same two serotypes (SI Table 2 ). However, because we were unable to identify a single PNSP isolate of serotype 9V in Sweden that did not belong to the Spain 9V -3 clone, the penicillin susceptible (PSP) strain BHN65 of ST239 was analyzed (SI Table 2 ). Microarray analysis identified a range of 156-237 genes that were absent (P Ͻ 0.01) in the six clinical isolates compared with R6/TIGR4. Most of these genes were annotated as hypothetical or of unknown function. A pairwise comparison of the gene content of the different isolates showed that strains belonging to clone ST156, even if belonging to different serotypes, were significantly (Welch two-sample t test, P Ͻ 0.0001) more similar compared with pneumococcal isolates of non-ST156 clusters (SI Table 3 ). Fig. 3A shows the 55 most significant genetic differences between the four ST156 isolates of serotypes 9V and 14, and the other non-ST156 isolates of the same two serotypes. A striking finding was the presence of the rlrA pilus islet (SP0461-SP0468) (8) in ST156 isolates, which was missing in the two strains of non-156 STs. This islet was recently shown to encode pneumococcal pili and has been demonstrated to promote bacterial adherence to cultured human respiratory epithelial cells and found to outcompete isogenic nonpiliated mutants in colonization of the upper respiratory tract of mice (6) . Another difference was the phospho-transferase system, spr0422-spr0423 (SP0475-SP0476), close to the rlrA islet, which was only present in the ST156 isolates. Conversely, a group of genes found in close proximity to one another, spr1747 (SP1931), spr1752 and spr1753, annotated to be of hypothetical function, were all absent in ST156 isolates. Furthermore, differences in gene content for two isolates of 19F of ST156 and of one 19F non-ST156 isolate are shown in Fig. 3A (see also below) . Interestingly, we found that one of the 19F isolates of ST156 lacked the rlrA islet. The expression of pneumococcal pili in the six ST156 isolates of type 9V, 14, and 19F was confirmed by Western blot analysis using antibodies to the major pilus subunit protein RrgB (Fig. 3B ). Additionally, we tested for the presence or absence of the rlrA pilus islet in 80 clinical isolates by PCR analysis (SI Table 4 ) (28 of serotype 9V and 52 of serotype 14). All isolates belonging to the clonal cluster of ST156 (n ϭ 67) harbored the rlrA islet. In contrast, 24 of 25 PNSP isolates of serotype 14 that belonged to non-ST156 clones lacked the rlrA islet (data not shown). These clonal types were identified at a lower frequency among PNSP isolates than those belonging to ST156, indicating that a genetic factor such as the rlrA islet may contribute to the fitness and spread of certain pneumococcal clonal clusters.
Capsular Switch Variants of ST156 Differ at Loci Within a 750-kb
Region Centred at the Capsular Locus. The genetic differences observed between the four ST156 isolates and the two non-ST156 related isolates were distributed evenly around the pneumococcal genome, which suggests that there was no bias for horizontal gene transfer events in the evolution of ST156. Comparison of the 9V isolates with type 14 isolates revealed a region called the R6 cluster1 (spr0111-spr0116) previously identified by Brückner et al. (9) . These genes were absent in the two serotype 14 variants of ST156 tested, but were present in the two 9V isolates. This region of hypothetical genes is also absent in the well characterized serotype 4 isolate TIGR4. Comparison of the differences within serotypes showed that whereas the 9V strains of ST156 only differed from one another at two loci, the two serotype 14 isolates of the same clone differed at nine loci (SI Table 3 and Fig. 3C ). Interestingly, the intraclonal differences found among the four ST156 isolates were not scattered around the chromosome but were localized to a region of Ϸ750 kb, with the capsular locus at its approximate center (Fig.  4) . This finding suggests that the horizontal transfer of capsular genes was associated with multiple transformation events derived from an originally much larger segment of pneumococcal DNA. The 750-kb region also encompasses the rlrA pilus islet. The full-length rlrA pilus islet was sequenced in both the type 9V isolate BHN68 and the type 14 isolate BHN81. Only 10 nt differed between the two isolates, in contrast to a 150-nt difference found when comparing the rlrA islet of ST156 isolates, with the rlrA islet of TIGR4. Hence, the rlrA islet of ST156 was retained despite recombination events occurring in association with capsular switches.
Penicillin Nonsusceptibility in ST156 Was Developed in a Susceptible
Piliated Ancestor Strain. To investigate whether the clonal success of the ST156 clone could be attributed to the development of antibi- Table 2 ) are shown. Also, differences between two 19F isolates of ST156 and one 19F isolate of ST425 are shown. Capsular genes are not included. Genes encoding the rlrA islet are marked in gray. (B) Western blot analysis of pneumococcal isolates belonging to serotypes 9V, 14, and 19F with ST156 or with three nonrelated STs using antibodies to the pilus protein RrgB. The extracts of strains BHN99 and BHN98 were concentrated 26 times by precipitation by trichloric acid. (C) Differences between isolates of serotypes 9V, 14, and 19F belonging to the same clone, ST156, are shown. Yellow indicates that the gene is present, dark blue indicates that it is absent (P Ͻ 0.01), and light blue indicates that it is likely to be absent but not statistically significant. Capsular genes are not included. Genes encoding for rlrA islet are marked in gray. otic resistance in an already piliated strain background, we further examined three PSP isolates belonging to ST162, a single locus variant of ST156. Of the nine ST162 isolates deposited in the MLST database, all but one are fully PSP, including the first reported isolate from 1994, suggesting that it represents the susceptible ancestor of ST156 (http://spneumoniae.mlst.net) (10) . ST162 has been isolated from U.K., Italy, Portugal, Brazil, and Canada over a number of years, showing that it is a successful, globally spreading PSP clone. PSP ST162 isolates are also common in Sweden, where they are found to display serotype 9V and 19F capsules, but not serotype 14. The three PSP isolates of ST162 carried the rlrA pilus islet and did express pili. The rlrA islets from these PSP isolates were sequenced and found to be almost identical (1-to 16-nt differences) to the islets found in PNSP of ST156. As expected, sequences differed at multiple sites from the rlrA islet of TIGR4 and other piliated isolates of unrelated STs (M.A.B., unpublished data). We also compared one of the PSP isolates of type 9V of ST162 (BHN62, SI Table 2 ) with the PNSP of ST156 by microarray analysis and found that only 27-41 loci differed compared with Ϸ100 loci for the non-ST156 isolates (SI Tables 3 and 5 ). One notable genetic difference was the previously described TIGR4 specific cluster 9 (8) that was only present in the penicillin-susceptible isolate of ST162 of type 9V. This difference, as well as others, could have been generated during the multiple horizontal gene transfer events required to create penicillin nonsusceptibility as well as resistance to trimetoprim/sulfametoxazole.
Low Abundance of ST156 Among Serotypes and Clones Already
Harboring the Pilus Islet. The most frequent serotypes among PNSP were 9V, 14, and 19F, which, combined, accounted for 61% of all PNSP in Sweden during 2003. In contrast to serotype 14, which exhibited a marked increase in frequency, we observed no increase in the number of PNSP of type 9V and 19F during 2000-2003 (Fig. 2 A) Table 6 ). Interestingly, no serotype 19F isolates with ST156 were found during these years. Instead, we observed that another internationally spreading PNSP clone, Taiwan 19F -14 of ST236 (13) as well as SLVs and double-locus variants (DLVs) of ST236, dominated among PNSP of serotype 19F, followed by a DLV of ST156 (Fig. 2B and SI Table 6 ). As expected, PNSP isolates of the DLVs of ST156 carried the rlrA pilus islet. Importantly, all isolates tested belonging to the dominant ST236 clonal cluster also carried the pilus islet. During 2000-2003, we estimate that 55% of all 19F PNSP isolates belonged to clones shown to carry the rlrA islet and therefore had the potential to express pili. In 2003, this figure increased to 82%, arguing for an overall increase in the proportion of piliated isolates among PNSP 19F.
The two 1997 serotype 19F isolates with ST156 (BHN98 and BHN99) were compared with one unrelated ST isolate with ST425 (BHN97) of serotype 19F and were characterized by microarray analysis and shown to differ at a diverse number of loci (Fig. 3A and C and SI Table 3 ). When BHN99 with ST156 was compared with the ST156 isolates of serotypes 9V and 14, a high degree of similarity was found (SI Table 3 and Fig. 3C ). Only one genetic locus differed between BHN99 (of 19F) and the serotype 14 isolate BHN81 (excluding capsular genes resulting from the capsular switch). Thus, a reason for the success of PNSP ST156 among serotypes 9V and 14 and its reduced success within serotype 19F could be explained by the absence of competing piliated PNSP clones among the former two serotypes in Sweden and the presence of another successful piliated clone within serotype 19F. To test this hypothesis, we analyzed 16 PNSP of serotype 6B and 21 PNSP of serotype 35B, common serotypes in Sweden (7, 11). We found that PNSP isolates of serotype 6B belonged to several clones by PFGE (data not shown) and that all but one carried the rlrA islet. Of the three 6B strains typed by MLST, two belonged to the international Spain 6B -2 clone and carried the pilus islet, whereas the third belonged to an unrelated clone lacking the rlrA islet. Complete sequencing of the rlrA islet from isolates of the Spain 6B -2 clone revealed that it was significantly divergent from the islet present in ST156. All but one of the 35B isolates tested here belonged to a single clone with ST558 and unrelated to ST156, carrying an rlrA islet also divergent from that present in ST156 (data not shown). The remaining 35B isolate, unrelated to ST156, lacked the rlrA islet. We did not find any PNSP isolates of serotypes 6B or 35B being of ST156, which is consistent with our hypothesis that clonal expansion of ST156 occurs among serotypes that are not dominated by piliated isolates of other clonal types.
Among the PNSP isolates (from 2003) with serotypes 6B, 9V, 14, 19F, and 35B, Ͼ90% percent belonged to a small number of rlrA carrying clones of which ST156 clonal cluster was dominating. Because we know the serotype distribution for all PNSP isolates in Sweden (7), we can infer that at least 70% of all Swedish PNSP isolates were piliated in 2003.
A Clinical ST156 Isolate, Lacking the rlrA Pilus Islet, Was Outcompeted in the Nasopharynx by a Related Piliated Isolate. If pili are essential for clonal success we would expect nonpiliated isolates of ST156 to be rare among healthy carriers and to be outcompeted by piliated isolates in the upper respiratory tract. Among 67 PNSP isolates belonging to the clonal cluster ST156 that were tested (with PCR and/or microarray) we identified only one carrier isolate that lacked the rlrA islet (BHN98 of serotype 19F). Microarray analyses revealed that BHN98 only differed from the 19F carrier isolate BHN99 with ST156 at one locus corresponding to the rlrA pilus islet. Western blot analysis confirmed that BHN98 lacked pili expression as described above (Fig. 3B) . These data implicated the discovery of a naturally occurring deletion mutant BHN98 (SI Table 3 and Fig. 3C ). To test the hypothesis that the rlrA islet is necessary for colonization in clinical isolates, we performed a competition ex- periment in which mice were inoculated intranasally with equal amounts of bacteria of BHN99 expressing pili and BHN98 lacking pili. Neither of these two ST156 carrier isolates from children (SI Table 2 ) caused invasive disease in mice (data not shown). In the nasopharynx however, the piliated isolate outcompeted the nonpiliated strain, suggesting that expression of pili in ST156 isolates provides a competitive advantage over nonpiliated pneumococci (Fig. 5) . Therefore, the presence of the rlrA islet may represent a genetic element contributing to the successful spread of the ST156 clone.
Presence of the rlrA Pilus Islet Correlate to Specific Clonal Types That
Are Common in Carriage. Next we wanted to compare the presence of the rlrA islet among Swedish PNSP isolates (at least 70%) to that of 93 arbitrarily chosen Swedish clinical isolates representative of different serotypes and clones from carriage or disease (SI Table 7 ). In this collection, 38% carried the rlrA islet. The islet was present in seven clonal clusters belonging to serotypes predominantly found among carriers. Notably, clones with serotypes primarily associated with invasive disease and not carriage such as serotype 1, 2, 3, and 7F lacked the islet, providing a further argument that piliation promotes nasopharyngeal colonization.
Concluding Remarks. The findings reported here suggest that pneumococcal pili may contribute to the global expansion of the penicillin nonsusceptible Spain 9V -3 clone (ST156). The frequent occurrence in the community of antibiotic susceptible isolates belonging to the same clonal cluster, suggests that antibiotic selection plays a relatively modest role in maintaining PNSP of ST156 in the carrier population, at least in a country like Sweden with a low antibiotic usage. Isolates belonging to the ST156 clonal cluster have been reported to express a variety of capsular types, several of which are not covered by the present 7-valent conjugative vaccine. With a widespread use of pneumococcal conjugate vaccine-7 (PCV-7) we can expect an expansion of nonvaccine types belonging to this clonal cluster. Pilus components were recently demonstrated to elicit protection in mice against lethal pneumococcal infection (14). Therefore, a protein-based vaccine that includes the pneumococcal pilus has the potential to eliminate piliated clones that are particularly prone to colonize the nasopharynx of healthy carriers. This in turn may eliminate an important reservoir for present and future antibiotic resistance in S. pneumoniae.
Materials and Methods
Clinical Pneumococcal Isolates Studied. Clinical pneumococcal isolates with a reduced susceptibility to penicillin [minimal inhibitory concentration (MIC)
for Infectious Disease Control. All isolates were serogrouped/typed, and the distribution has been described by Högberg et al. (7) . A total of 654 isolates of serotype 9V, 455 isolates of serotype 14, and 326 isolates of type 19F from 2000-2003 were further analyzed with serotyping and antibiotic susceptibility. All type 14 and 19F isolates and 80 randomly selected 9V isolates were also studied by molecular typing with PFGE, and selected isolates were subjected to MLST (see below). In addition, 16 isolates of type 6B and 21 isolates of type 35B were characterized by PFGE, and some were also characterized by MLST.
Eighty pneumococcal isolates (28 of serotype 9V and 52 of serotype 14; 3 from invasive disease, 10 from respiratory or other diseases, and 67 from carriage) were subjected to PCR analysis studying the presence of the rlrA islet. In addition, 93 pneumococcal isolates, chosen to represent different serotypes and clones from disease and carriage, were subjected to analysis of the presence of the rlrA islet by either PCR in combination with Southern blot analysis, microarray analysis or sequencing, or only sequencing (SI Table 7 ).
Bacteriology and Serotyping. All pneumococcal isolates were serotyped at the Swedish Institute for Infectious Disease Control by gel diffusion as described in ref. 12.
Drug-Susceptibility Testing. All isolates were tested for drug susceptibility by using disk diffusion and E test as described in ref. 12.
Molecular Typing. Two molecular typing methods were used, PFGE and MLST. All isolates were characterized by PFGE, and representatives of the clones identified were further characterized with MLST. In total, 861 isolates were subjected to PFGE analysis, including all type 14 isolates (n ϭ 455), all type 19F isolates (n ϭ 326), as well as 80 type 9V isolates (20 PFGE. The PFGE method was adapted from the procedure described by Hermans et al. (15) . The gels were analyzed by using the program BioNumerics version 4.5 (Applied Math, Sint-MartensLatem, Belgium), with the Jaccard coefficient and unweighted pair group method with arithmetic mean (UPGMA) dendrogram type. The optimization setting was 1% with a position tolerance of 2%. The clones were defined using the criteria described by Tenover et al. (16) , i.e., isolates that differed with Յ3 bands were considered to be closely related. Representatives of all clones found with PFGE were subjected to MLST analysis (see below and SI Tables 1 and 6 ).
MLST. In total, 36 type 14, 12 type 9V, 38 type 19F, 3 type 6B, and 4 type 35B isolates selected to be different with PFGE were subjected to MLST. This method was adapted from the procedure described by Enright et al. (17) . Chromosomal DNA from pneumococcal isolates were subjected to sequencing of seven different housekeeping genes, aroE, gdh, gki, recP, spi, xpt, and ddl by using an ABI 3130 XL (Applied Biosystems, Foster City, CA). The sequences obtained were submitted to the MLST database on the Internet and were thereby assigned alleles at each locus and a ST.
PCR Method. Chromosomal DNA was extracted using GFX Genomic Blood DNA purification kit (Amersham Biosciences, Little Chalfont, U.K.). Synthetic oligonucleotide primers (Invitrogen, Carlsbad, CA) used in PCR amplifications are listed in SI Table  4 . PCR was carried out using Thermoprime Plus DNA polymerase (ABGene, Epsom, U.K.). Southern Blot Analysis. DNA was prepared by the DNEasy Tissue Kit (Qiagen, Valencia, CA), digested by EcoRI and SacI, respectively, and incubated at 37°C over night. Samples were run on 0.8% Seakem agarose gel, depurinated in 250 mM NaCl, and washed in 0.4M NaOH. Blotting was made using ECL Direct Nucleic Acid Labeling and Detection Systems (Amersham Bioscences). Probes were generated by PCR amplification of TIGR4 genomic DNA with the gene-specific primer pairs listed in SI Table 4 .
Microarray Analysis. Hybridization. Comparative genome hybridizations were carried out on 10 clinical isolates (listed in SI Table 2 ) by using a reference design. Twenty-two additional isolates were studied for the presence of the rlrA islet (SI Table 7 ). The microarray for S. pneumoniae consists of 2.797 50-mer oligonucleotides (MWG Biotech, Edensberg, Germany) spotted in triplicates in random order on glass slides. (Qarray arrayer; Genetix, Boston, MA) (MWG Epoxy Slides; MWG Biotech). Oligonucleotides were based on predicted ORFs of the two fully sequenced strains R6 (18) and TIGR4 (19) .
Genomic DNA was prepared from plate-grown bacteria by genomic DNA buffer set (Qiagen). Cy dye-labeling of 2 g of genomic DNA each of the test isolate and the reference (the latter being an equimolar mix of TIGR4 and R6 DNA) was performed in a modified version from www.ifrn.bbsrc.ac.uk/safety/microarrays/ protocols.html#DirectDNAlabeling.
The hybridization was carried out at 42°C for 14 h in an automated hybridization station (TECAN HS400; Tecan Group, Maennedorf, Switzerland). The slides were washed with 5ϫ SSC ϩ 0.1% SDS, 1ϫ SSC ϩ 0.1% SDS, 0.1ϫ SSC ϩ 0.1% SDS, and 0.1 SSC in given order. Analysis. The microarrays were scanned in a GenePix 4000B scanner (Molecular Devices/Axon Instruments, Union City, CA) at 532 nm and 635 nm. Signal intensities were quantified using Genepix Pro 6.0 software (Axon Instruments, Union City, CA). For each spot, the median pixel intensity was calculated and assigned to that particular spot. Spots showing signals, without background subtraction, lower than background plus two standard deviations, being saturated, or showing obvious abnormalities were excluded from subsequent statistical analysis. For each of the 10 test isolates we performed four replicate experiments, including two dye-swap experiments per isolate, except for BHN62, for which three replicate experiments were performed. The log 2 fluorescence ratios were normalized to the median by using the R Project for Statistical Computing. (www.r-project.org). For statistical analysis we use a Bayesian linear model (20) and the Holm multiple testing correction to adjust individual P values. This method was used to compare the isolates to the two reference strains as well as to each other.
Genes were considered absent if they had a P value Ͻ0.01 within an M value ϽϪ1. Limitations. The statistical analysis of the microarray data were performed under rather stringent conditions, meaning a greater likelihood for false positives (i.e., genes considered present) than for false negatives (genes considered absent). Because of this, the presence and absence of several of the genes that differ within the ST156 clone have been confirmed by PCR and/or Western blot analysis. Also, we observed the occurrence of false negatives in, e.g., SP0466, due to differences in sequence. This difference in sequence is why only six and not seven of the pili genes differ between the two 19F ST156 isolates according to the microarray results. In this particular case, the gene was sequenced to confirm its presence. Also, the microarray method will not allow detection of new genes not present on the chip.
Western Blot Analysis. Western blot analysis using RrgB antibodies (mice immune sera) was performed as described in ref. 6 .
Mouse Challenge. The clinical 19F isolates with ST156, BHN99, and BHN98, were grown in CϩY medium until OD 620 ϭ 0.5 and mixed equally at 1:1. Twenty microliters (Ϸ2 ϫ 10 6 cfu) were used for intransal challenge of 6-to 8-week-old male C57BL/6 (wild-type) mice as described previously in competition assays (6) . After 7 days, mice were killed and naso-tracheal lavages were collected. The output of BHN98 cfu compared with BHN99 cfu was determined using PCR for the rlrA pilus-islet on 24 randomly picked colonies per mouse. Primers used in the first round were SP0462R/F and in the second round for those negative in the first PCR, pilidn, and piliup (see SI Table 4 ). The competitive index (CI) was calculated as described in ref. 6 . The experiment was run twice with six mice each time. The experiments have been approved by the local ethical committee for animal research.
